
Board Meeting19 Nov 2026, 06:10 pm
Dipna Pharmachem Board Approves Capital Increase & Related Party Transactions
AI Summary
Dipna Pharmachem Ltd announced that its Board of Directors met on September 8, 2026. The board approved an increase in the authorized share capital from Rs. 28.50 Crore to Rs. 32.00 Crore, subject to shareholder approval. Additionally, the board recommended material related party transactions with Ohara Pharmachem Private Limited, Dipan Pharmachem Private Limited, Cedac Medicorp, Dhara Chemicals, and Dipan Pharma Chern for shareholder approval at the upcoming Annual General Meeting (AGM). The company also approved the notice for its 15th AGM, scheduled for September 30, 2026.
Key Highlights
- Authorized share capital increased from Rs. 28.50 Crore to Rs. 32.00 Crore.
- Recommended material related party transactions for shareholder approval.
- AGM scheduled for September 30, 2026.
- Board meeting concluded within 1 hour and 15 minutes.
- Alteration of the Capital clause in Memorandum of Association approved.
Price Impact
More from DPL